Board of Directors

Martin B. Wax, MD

Chairman of the Board

President & CEO Mimetogen Pharmaceuticals

Read More »
David Guyer, MD, PhD

Dr. Guyer re-joined SV Life Sciences, a venture capital firm focused on healthcare, in 2021 as venture partner where he has previously been both venture partner and partner from 2006 to 2013 until he founded Ophthotech (now Iveric Bio), a biotech focused on the discovery and development of treatments for retinal diseases.

Dr. Guyer also co-founded Eyetech Pharmaceuticals Inc. and served as its Chief Executive Officer and as a member of its Board of Directors from 2000 until it was acquired by OSI Pharmaceuticals, Inc. in November 2005. Prior to co-founding Eyetech Pharmaceuticals, Dr. Guyer was a professor and served as Chairman of the Department of Ophthalmology at New York University School of Medicine.

Dr. Guyer received a B.S. from Yale College and an M.D. from Johns Hopkins Medical School. Dr. Guyer completed his ophthalmology residency at Wilmer Ophthalmological Institute, Johns Hopkins Hospital and a retinal fellowship at the Massachusetts Eye and Ear Infirmary at Harvard Medical School.

See More »
Kevin Giese

Mr. Kevin Giese was the founder of BioMS Medical Corp. which company raised over $280 million, and in 2008 was designated Biotech Company of the year in Canada and awarded the Scrips Award for Best International Licensing Deal.

Mr. Giese has been on the board of directors of a number of private and publicly listed companies, including Spectral Diagnostics Inc. since March 2010, and Mimetogen Pharmaceuticals Inc. since October 2011.

He has been a member of the board of directors of BioAlberta, an advisory member of the Institute of Corporate Directors (Canada) and has received awards for entrepreneurship from BioAlberta and Ernst & Young. Mr. Giese has a B.A., a law degree and an M.B.A.

Go »
Francois Mongrain, CA CPA

Vice President Finance & Chief Financial Officer Mimetogen Pharmaceuticals